Join
Live feed
·
PRReleasevia Quantisnow
Immuneering Corporation logo

Immuneering to Report Third Quarter 2025 Financial Results and Provide New Clinical Case Studies, on Wednesday, November 12, 2025

ByQuantisnow·Wall Street's wire, on your screen.
IMRX· Immuneering Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMRX (Immuneering Corporation) and more on Quantisnow.